Very low calorie diet
Very low calorie diet (VLCD) is a diet with very or extremely low daily food energy consumption. It is defined as a diet of 800 kilocalories (3,300 kJ) per day or less. VLCDs are formulated, nutritionally complete, liquid meals containing 800 kilocalories or less per day. VLCDs also contain the recommended daily requirements for vitamins, minerals, trace elements, fatty acids and protein. Carbohydrate may be entirely absent, or substituted for a portion of the protein; this choice has important metabolic effects. The VLCD products are usually a powder which is mixed with water or another low-food-energy liquid. The VLCD is prescribed on a case to case basis for rapid weight loss (about 1.5 to 2.5 kilograms or 3 to 5 pounds per week) in people with Body Mass Index of 30 and above. The health care provider can recommend the diet to a patient with a BMI between 27 and 30 if the medical complications the patient has due to being overweight present serious health risks. It results in 4% more weight loss over the short term as compared to control.
A 1997 study concludes that the short-term use of a VLCD is very effective in rapidly improving glycaemic control and promoting substantial weight loss in obese patients with Type 2 diabetes. Moreover, a VLCD increases insulin sensitivity and reduces the substrate for gluconeogenesis. Thus VLCD treatment may improve glycaemic control more than calorie restriction alone. A VLCD is typically undertaken by an obese patient who wishes to lose a lot of weight quickly, as the risk to health that obesity presents is considered much greater than any risks of the diet itself, so long as it is undertaken with medical supervision.
Studies have shown that in about one in four individuals following a VLCD for a few months, gallstones develop. However, these gallstones may be small enough to not cause discomfort, and often disappear when a normal eating pattern is resumed. Gallstone formation is facilitated by the more concentrated bile fluid and reduced flow as a result of a VLCD. Another potential side effect is constipation (depending on the fiber content of the diet). Unmonitored VLCDs with insufficient macronutrient and mineral intake have the potential to cause sudden death via ventricular tachycardia.
- Howard AN (1981). "The historical development, efficacy and safety of very-low-calorie diets". Int J Obes. 5 (3): 195–208. PMID 7024153.
- "Very Low Calorie Diet for Rapid Weight Loss". Calorie Counter. Retrieved 2010-10-19.
- Gudzune, KA; Doshi, RS; Mehta, AK; Chaudhry, ZW; Jacobs, DK; Vakil, RM; Lee, CJ; Bleich, SN; Clark, JM (7 April 2015). "Efficacy of commercial weight-loss programs: an updated systematic review.". Annals of Internal Medicine. 162 (7): 501–12. doi:10.7326/m14-2238. PMID 25844997.
- Capstick F, Brooks BA, Burns CM, Zilkens RR, Steinbeck KS, Yue DK (May 1997). "Very low calorie diet (VLCD): a useful alternative in the treatment of the obese NIDDM patient". Diabetes Res. Clin. Pract. 36 (2): 105–11. doi:10.1016/s0168-8227(97)00038-7. PMID 9229194.
- Diabetes for Professionals – VLCD in the treatment of obese patients with Type 2 diabetes: does it make sense?
- Andersen T (July 1992). "Liver and gallbladder disease before and after very-low-calorie diets". Am. J. Clin. Nutr. 56 (1 Suppl): 235S–239S. PMID 1615889.
- Broomfield PH, Chopra R, Sheinbaum RC, Bonorris GG, Silverman A, Schoenfield LJ, Marks JW (December 1988). "Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight". N. Engl. J. Med. 319 (24): 1567–72. doi:10.1056/NEJM198812153192403. PMID 3200265.
- Liddle RA, Goldstein RB, Saxton J (August 1989). "Gallstone formation during weight-reduction dieting". Arch. Intern. Med. 149 (8): 1750–3. doi:10.1001/archinte.1989.00390080036009. PMID 2669662.
- Astrup A, Vrist E, Quaade F (February 1990). "Dietary fibre added to very low calorie diet reduces hunger and alleviates constipation". Int J Obes. 14 (2): 105–12. PMID 2160441.
- Astrup A, Quaade F (1989). "VLCD compliance and lean body mass". Int J Obes. 13 Suppl 2: 27–31. PMID 2559044.